Rosiglitazone and Gemcitabine in combination reduces immune suppression and modulates T cell populations in pancreatic cancer - Concepedia

Concepedia

Publication | Open Access

Rosiglitazone and Gemcitabine in combination reduces immune suppression and modulates T cell populations in pancreatic cancer

DOI Full Paper Access

62

Citations

41

References

2012

Year

Stephanie K. Bunt, Ashley M. Mohr, Jennifer M. Bailey, Paul M. Grandgenett, Michael A. Hollingsworth

Cancer Immunology Immunotherapy

Pancreatic CancerMedicineImmunologyImmune Checkpoint InhibitorT Cell PopulationsOncologyCell BiologyTumor MicroenvironmentCancer Research

References

	Year	Citations

Page 1